Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Clinical trial NCT07734038 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07734038
- Sponsor
- Kerry Rogers
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-07
- Primary completion
- 2027-12-31
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.